Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,457 Mln
P/E Ratio
--
P/B Ratio
2.36
Industry P/E
--
Debt to Equity
0.02
ROE
-0.02 %
ROCE
-1.9 %
Div. Yield
0 %
Book Value
7.61
EPS
-0.18
CFO
$84.35 Mln
EBITDA
$114.10 Mln
Net Profit
$-606.14 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Mirion Technologies Inc. Class A (MIR)
| -12.21 | -0.91 | -15.41 | 38.77 | 22.67 | -- | -- |
|
BSE Sensex*
| 2.52 | 3.37 | 6.44 | 8.80 | 12.18 | 20.37 | 11.43 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Mirion Technologies Inc. Class A (MIR)
| 69.51 | 55.07 | -36.87 | -3.94 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 52.53 | 10,371.26 | 24.66 | 26.1 | |
| 137.30 | 11,116.98 | 21.79 | 19.59 | |
| 185.76 | 10,408.11 | 22.82 | 35.36 | |
| 61.58 | 9,568.98 | 32.58 | 3.31 |
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers... radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia. Read more
Founder, Medical Group President, CEO & Director
Mr. Thomas D. Logan
Founder, Medical Group President, CEO & Director
Mr. Thomas D. Logan
Headquarters
Atlanta, GA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Mirion Technologies Inc Class A (MIR) stood at $ 2,636 Mln as on 31-Dec-24
The share price of Mirion Technologies Inc Class A (MIR) is $15.32 (NYSE) as of 25-Apr-2025 16:00 EDT. Mirion Technologies Inc Class A (MIR) has given a return of 22.67% in the last 3 years.
Mirion Technologies Inc Class A (MIR) has a market capitalisation of $ 3,457 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Mirion Technologies Inc Class A (MIR) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Mirion Technologies Inc Class A (MIR) and enter the required number of quantities and click on buy to purchase the shares of Mirion Technologies Inc Class A (MIR).
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.
The CEO & director of Mr. Thomas D. Logan. is Mirion Technologies Inc Class A (MIR), and CFO & Sr. VP is Mr. Thomas D. Logan.
There is no promoter pledging in Mirion Technologies Inc Class A (MIR).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,071
|
|
|
1,014
|
|
|
983
|
|
|
914
|
| Mirion Technologies Inc. Class A (MIR) | Ratios |
|---|---|
|
Return on equity(%)
|
-2.37
|
|
Operating margin(%)
|
2.79
|
|
Net Margin(%)
|
-4.19
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Mirion Technologies Inc Class A (MIR) was $0 Mln.
$0.39
(
